RNASEH2B and cervical carcinoma: This notion was also suggested by others showing that knocking out RNASEH2A in cervical cancer HeLa cells results in an increased sensitivity to ataxia telengiectasia and Rad3-related (ATR) inhibitors compared to knocking out RNASEH2B [48].